Giridharan Periyasamy

10 Biopolis Way, Chromos
Singapore, 138670, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Identification of Cyclin L1 as a Host Factor Regulating Hepatitis B Virus Replication.

Identification of Cyclin L1 as a Host Factor Regulating Hepatitis B Virus Replication.

Journal: Viruses

Published: March 31, 2026

Utility of combined solid and liquid biopsy for molecular profiling in lung adenocarcinoma: Insights from a real-world case.

Utility of combined solid and liquid biopsy for molecular profiling in lung adenocarcinoma: Insights from a real-world case.

Journal: The journal of liquid biopsy

Published: April 14, 2025

Deep Diving Into the Fusion Across Cancer Types in the Indian Population From Formalin-Fixed Paraffin-Embedded RNA-Exome Data: A Road to Discovering Novel Rearrangements With Clinical Relevance.

Deep Diving Into the Fusion Across Cancer Types in the Indian Population From Formalin-Fixed Paraffin-Embedded RNA-Exome Data: A Road to Discovering Novel Rearrangements With Clinical Relevance.

Journal: JCO global oncology

Published: November 21, 2024

CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancer.

CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancer.

Journal: Cell reports. Medicine

Published: July 21, 2024

Single-cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity.

Single-cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity.

Journal: Journal of hepatology

Published: December 29, 2022

Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress.

Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress.

Journal: International journal of molecular sciences

Published: January 27, 2022

Genome-wide screens identify specific drivers of mutant hTERT promoters.

Genome-wide screens identify specific drivers of mutant hTERT promoters.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 04, 2021

Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma.

Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma.

Journal: Frontiers in oncology

Published: May 14, 2021

Corrigendum to 'A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)'.

Corrigendum to 'A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)'.

Journal: EBioMedicine

Published: April 16, 2021

A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC).

A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC).

Journal: EBioMedicine

Published: June 17, 2020

Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation.

Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation.

Journal: Nature communications

Published: March 04, 2019

New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.

New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.

Journal: Gastroenterology

Published: January 03, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026